AgingResearch.NewsJoin free

Yangyin fuzheng jiedu prescription

Intervention

1 paper3 findings

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

  • 1 lab in 1 country
  • Human trial1

Outcomes

3

FOXO1

upin mice1

1 study

  1. Yangyin fuzheng jiedu prescription increases FOXO1 in mice.

    “YFJP treatment increased the expression of FoxO1 in CD8+ T cells.”

    AnimalsCD8+ T cells

    FoxO1 as a Hub in Immunosenescence Induced by Hepatocellular Carcinoma and the Effect of Yangyin Fuzheng Jiedu Prescription

    Drug design, development and therapyMar 5, 2025

More on FOXO1

Cellular senescence

downin mice1

1 study

  1. Yangyin fuzheng jiedu prescription decreases cellular senescence in mice.

    “YFJP treatment ameliorated CD8+ T cell senescence in tumor-bearing mice.”

    Animalsin tumor-bearing mice

    FoxO1 as a Hub in Immunosenescence Induced by Hepatocellular Carcinoma and the Effect of Yangyin Fuzheng Jiedu Prescription

    Drug design, development and therapyMar 5, 2025

More on Cellular senescence

CD8+ T cell

upin humans1

1 study

  1. Yangyin fuzheng jiedu prescription increases CD8+ T cell in humans.

    “YFJP treatment increased the proportion of CD8+ T cells.”

    Human trialin HCC patients

    FoxO1 as a Hub in Immunosenescence Induced by Hepatocellular Carcinoma and the Effect of Yangyin Fuzheng Jiedu Prescription

    Drug design, development and therapyMar 5, 2025

More on CD8+ T cell

Latest

Related